Geriatric Medicine Doctors in Seal Beach, CA Accepting Medicare

4 Geriatric Medicine doctors found. Showing 1 - 4

Ellen Dayon, MD Internal Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 1661 Golden Rain Rd, Seal Beach, CA 90740 Phone: 562-493-9581

Mary B Sherman, MD Internal Medicine - Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 1661 Golden Rain Rd, Seal Beach, CA 90740 Phone: 562-493-9581

Christopher P Nguyen, MD Internal Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 13930 Seal Beach Blvd, Seal Beach, CA 90740 Phone: 562-430-8888    Fax: 562-799-0077

Prakash Narain, MD Internal Medicine - Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 1661 Golden Rain Rd, Seal Beach, CA 90740 Phone: 562-493-9581    Fax: 562-430-6795

News Archive

British government urging doctors to dissuade unnecessary Caesarean births

Guidelines from the National Institute for Clinical Excellence say doctors should allow a woman to choose how she gives birth. They also say that women must be informed of the risks and benefits of different ways of having a baby.

Amgen's Vectibix (panitumumab) receives EC approval for treatment patients with WT RAS mCRC

Amgen today announced that the European Commission approved a new use of Vectibix (panitumumab) as first-line treatment in combination with FOLFIRI for the treatment of adult patients with wild-type (WT) RAS metastatic colorectal cancer (mCRC).

Tahitian Noni International wins Excelsis Awards

The Global Quality Foundation announced that Tahitian Noni International (TNI) Mexico is this year's winner of two Excelsis Awards - one for excellence in product quality, and the other for research and development. The Global Quality Foundation is a multifaceted organization that searches for improvements in quality processes, products and services that satisfy the needs of the current global society.

Results from Phase I dose-escalation study of AT-101 announced

Ascenta Therapeutics announced today that encouraging results from a Phase I dose-escalation study of two combination therapy regimens containing AT-101, an oral, pan-Bcl-2 inhibitor, in patients with the most malignant type of brain tumor, were described in an oral presentation at the 2009 Joint Meeting of the Society for NeuroOncology (SNO) and AANS/CNS Section on Tumors in New Orleans, Louisiana (Concurrent Session VI: Radiation Oncology, October 23, 2009; Abstract # 449).

Read more Medical News

› Verified 9 days ago